{
  "id": "56c8274f5795f9a73e00000d",
  "type": "factoid",
  "question": "Which type of cells is affected in Amyotrophic Lateral Sclerosis?",
  "ideal_answer": "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which motor neurons are affected.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23197818",
    "http://www.ncbi.nlm.nih.gov/pubmed/24269728",
    "http://www.ncbi.nlm.nih.gov/pubmed/20846186",
    "http://www.ncbi.nlm.nih.gov/pubmed/22900096",
    "http://www.ncbi.nlm.nih.gov/pubmed/24971881",
    "http://www.ncbi.nlm.nih.gov/pubmed/22797053",
    "http://www.ncbi.nlm.nih.gov/pubmed/25384799",
    "http://www.ncbi.nlm.nih.gov/pubmed/23114367"
  ],
  "snippets": [
    {
      "text": "Activation of microglia, CNS resident immune cells, is a pathological hallmark of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder affecting motor neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24269728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24971881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neurodegenerative disease characterized by ascending muscle weakness, atrophy and paralysis. Early muscle abnormalities that precede motor neuron loss in ALS may destabilize neuromuscular junctions, and we have previously demonstrated alterations in myogenic regulatory factor (MRF) expression in vivo and in the activation of myofiber-associated skeletal muscle satellite cells (SMSCs) in the mouse model of ALS (SOD1-G93A).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22797053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22900096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the ALS motor neurons, TAR DNA-binding protein of 43 kDa (TDP-43) is dislocated from the nucleus to cytoplasm and forms inclusions, suggesting that loss of a nuclear function of TDP-43 may underlie the pathogenesis of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22900096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Development of an in vitro model system for ALS is expected to help in obtaining novel insights into disease mechanisms and discovery of therapeutics. We report the establishment of an in vitro FALS model from human embryonic stem cells overexpressing either a wild-type (WT) or a mutant SOD1 (G93A) gene and the evaluation of the phenotypes and survival of the spinal motor neurons (sMNs), which are the neurons affected in ALS patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23197818",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Amyotrophic lateral sclerosis is the most common adult-onset motor neuron disease and evidence from mice expressing amyotrophic lateral sclerosis-causing SOD1 mutations suggest that neurodegeneration is a non-cell autonomous process where microglial cells influence disease progression",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25384799",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In amyotrophic lateral sclerosis (ALS), affecting the motoneurones of the central nervous system (CNS), stem cell-based therapy aims to replace dying host motoneurones by transplantation of cells in disease-affected regions",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846186",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In amyotrophic lateral sclerosis, spasticity is traditionally thought to be the result of degeneration of the upper motor neurons in the cerebral cortex, although degeneration of other neuronal types, in particular serotonergic neurons, might also represent a cause of spasticity. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Stem cell research raises hopes for incurable neurodegenerative diseases. In amyotrophic lateral sclerosis (ALS), affecting the motoneurones of the central nervous system (CNS), stem cell-based therapy aims to replace dying host motoneurones by transplantation of cells in disease-affected regions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20846186",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Motor neurons"
}